CoChat
Sign Up
Cited by 205Systemic Lupus Erythematosus ResearchReproductive System and PregnancyPregnancy and preeclampsia studies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study

Open access
Saccone, Gabriele, Berghella, Vincenzo, Maruotti, Giuseppe Maria, Ghi, Tullio, Rizzo, Giuseppe, Simonazzi, Giuliana, Rizzo, Nicola, Facchinetti, Fabio, Dall’Asta, Andrea, Visentin, Silvia, Sarno, Laura, Xodo, Serena, Bernabini, Dalila, Monari, Francesca, Roman, Amanda, Eke, Ahizechukwu Chigoziem, Hoxha, Ariela, Ruffatti, Amelia, Schuit, Ewoud, Martinelli, Pasquale·2017·American Journal of Obstetrics and Gynecology
DOI 10.1016/j.ajog.2017.01.026
Open this paper in CoChat — free account

Abstract

Background Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I, and lupus anticoagulant are the main autoantibodies found in antiphospholipid syndrome. Despite the amassed body of clinical knowledge, the risk of obstetric complications that are associated with specific antibody profile has not been well-established. Objective The purpose of this study was to assess the risk of obstetric complications in women with primary antiphospholipid syndrome that is associated with specific antibody profile. Study design The Pregnancy In Women With Antiphospholipid Syndrome study is a multicenter, retrospective, cohort study. Diagnosis and classification of antiphospholipid syndrome were based on the 2006 International revised criteria. All women included in the study had at least 1 clinical criteria for antiphospholipid syndrome, were positive for at least 1 antiphospholipid antibody (anticardiolipin antibodies, anti-β2 glycoprotein-I, and/or lupus anticoagulant), and were treated with low-dose aspirin and prophylactic low molecular weight heparin from the first trimester. Only singleton pregnancies with primary antiphospholipid syndrome were included. The primary outcome was live birth, defined as any delivery of a live infant after 22 weeks gestation. The secondary outcomes were preeclampsia with and without severe features, intrauterine growth restriction, and stillbirth.…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2017.01.026

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

See all 205

Related

See all

Metadata

Authors
Saccone, G., Berghella, V., Maruotti, G. M., Ghi, T., Rizzo, G., Simonazzi, G., Rizzo, N., Facchinetti, F., Dall’Asta, A., Visentin, S., Sarno, L., Xodo, S., Bernabini, D., Monari, F., Roman, A., Eke, A. C., Hoxha, A., Ruffatti, A., Schuit, E., & Martinelli, P.
Affiliations
  • University of Naples Federico II (IT)
  • Thomas Jefferson University (US)
  • University of Parma (IT)
  • University of Rome Tor Vergata (IT)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • University of Modena and Reggio Emilia (IT)
  • University of Padua (IT)
  • University of Udine (IT)
  • Johns Hopkins University (US)
  • Stanford Medicine (US)
Corresponding author
Saccone, Gabriele
ORCID
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2017-05
Volume
216
Issue
5
Pages
525.e1-525.e12
ISSN
0002-9378 (ISSN-L)
DOI
10.1016/j.ajog.2017.01.026
OpenAlex
W2580867287
Cited by
205
References
31
Citations by year
2026: 7 · 2025: 17 · 2024: 24 · 2023: 22 · 2022: 31 · 2021: 19 · 2020: 21 · 2019: 35 · 2018: 20 · 2017: 9
FWCI
20.34
Type
journal article
Language
en
Open access
Licence
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
primary antiphospholipid syndrome, pregnancy complications, live birth, preeclampsia, fetal growth restriction, stillbirth, anticardiolipin antibodies, anti-beta2-glycoprotein I antibodies, lupus anticoagulant, low-dose aspirin, low molecular weight heparin, pregnancy outcomes
MeSH terms
Adult, Anticoagulants, Aspirin, Female, Fetal Growth Retardation, Heparin, Low-Molecular-Weight, Humans, Italy, Platelet Aggregation Inhibitors, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Retrospective Studies, Cohort Studies, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, Stillbirth, Live Birth, beta 2-Glycoprotein I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review